UnitedHealth Group Incorporated $UNH Shares Acquired by West Family Investments Inc.

West Family Investments Inc. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 214.7% during the second quarter, Holdings Channel.com reports. The firm owned 3,100 shares of the healthcare conglomerate’s stock after purchasing an additional 2,115 shares during the quarter. West Family Investments Inc.’s holdings in UnitedHealth Group were worth $1,288,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Sarver Vrooman Wealth Advisors purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $25,000. Aberdeen Wealth Management LLC acquired a new stake in UnitedHealth Group in the second quarter valued at $31,000. Nalls Sherbakoff Group LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $27,000. Lifetime Wealth Management P.C. acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $29,000. Finally, Wilkerson Advisory Group LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the subject of several research analyst reports. Royal Bank Of Canada upped their price objective on shares of UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. Barclays lifted their target price on shares of UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a report on Monday, July 20th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, September 2nd. Mizuho lifted their target price on UnitedHealth Group from $470.00 to $493.00 and gave the company an “outperform” rating in a research note on Monday, July 20th. Finally, Piper Sandler set a $477.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $456.56.

Insider Buying and Selling

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 1.0%

Shares of UnitedHealth Group stock traded up $4.12 during trading hours on Tuesday, reaching $401.25. 7,048,300 shares of the company’s stock were exchanged, compared to its average volume of 7,640,271. The firm has a market capitalization of $360.16 billion, a price-to-earnings ratio of 25.82, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The company has a fifty day moving average of $410.91 and a 200-day moving average of $366.22.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the company earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group’s payout ratio is 59.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.